Editor-in-chief
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
☩Howard Morris Australia
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
☩Jill Tate Australia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada


Publisher
Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Arianna Lucini Paioni
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282
email: biochimica.clinica@sibioc.it



Area soci
Non possiedi o non ricordi la password!
Clicca qui

BC: Articoli scritti da F. Verdesca

Duplicazione sul cromosoma 22q11.21 in una paziente con difetto cardiaco congenito
Chromosome 22q11.21 duplication in a patient with congenital heart defect
C. Munno  |  F. Verdesca  |  A. Vitale  |  B. Lombardo  |  L. Pastore  | 
<p>The newly described 22q11.2&nbsp;microduplication syndrome is an association of a broad clinical spectrum and up to now more than 50 unrelated cases&nbsp;have been reported. The clinical presentation of patients is extremely variable and shares features with 22q11.2&nbsp;deletion syndromes (DG/VCFS), including heart defects, urogenital abnormalities, velopharyngeal insufficiency with&nbsp;or without cleft palate; it ranges from multiple defects to mild learning difficulties with some individuals being&nbsp;essentially normal. A high resolution array comparative genomic hybridization (a-CGH) 4x180K was performed on a&nbsp;patient with a congenital heart defect, a pulmonary valve stenosis, in order to identify potential mutations and to&nbsp;characterize the clinical phenotype at molecular level. Using a-CGH analysis, we identified a duplication in 22q11.21&nbsp;region of approximately 2.5 Mbp containing several genes including TBX1. The obtained results demonstrate the&nbsp;relevance of a-CGH as a screening method to detect genomic rearrangements responsible for congenital heart&nbsp;defects.</p>
Biochimica Clinica ; 39(4) e1-e3
Casi clinici - Case report